GREGORY P HANSON Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for GREGORY P HANSON.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of GREGORY P HANSON. GREGORY P HANSON is Vice President, CAO in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Vice President, Finance in AVANIR PHARMACEUTICALS, INC. ($AVNR) and VP, CAO & Secretary in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Chief Financial Officer in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and CHIEF FINANCIAL OFFICER, SECR in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).

Latest Insider Trading Transactions of GREGORY P HANSON

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AVNR, MBVX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA2.04195,000397,800195,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA2.04195,000397,800195,000
Jan 18 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9241,87338,523320,013361.9 K to 320 K (-11.57 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseM0.00449,15900
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9611,23210,783361,886373.1 K to 361.9 K (-3.01 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9838,69737,923373,118411.8 K to 373.1 K (-9.40 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9666,55063,888411,815478.4 K to 411.8 K (-13.91 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyM0.00449,1590478,36529.2 K to 478.4 K (+1,537.90 %)
Oct 04 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA0.00340,4200340,420
Sep 18 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA0.00108,7390108,739
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseS6.293,11919,6190
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseS5.553,11917,3100
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyP0.004,842038,33433.5 K to 38.3 K (+14.46 %)
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyP1.754,2867,50133,49229.2 K to 33.5 K (+14.68 %)
Apr 14 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.003,8857,77029,20633.1 K to 29.2 K (-11.74 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.0020040033,09133.3 K to 33.1 K (-0.60 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.0040080033,29133.7 K to 33.3 K (-1.19 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.0145090233,69134.1 K to 33.7 K (-1.32 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.158671,86234,14135 K to 34.1 K (-2.48 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.151,8003,87235,00836.8 K to 35 K (-4.89 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.251,0002,25036,80837.8 K to 36.8 K (-2.64 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseM0.0021,064021,063
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyM0.0021,064037,80816.7 K to 37.8 K (+125.80 %)
Feb 08 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA2.9975,000224,25075,000
Jan 03 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA3.3826,40089,23226,400
Aug 30 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA5.0026,400132,00026,400
Aug 19 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseP6.293,11919,6193,119
Aug 19 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseP5.553,11917,3103,119
Aug 19 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyP0.003,119016,74413.6 K to 16.7 K (+22.89 %)
Apr 05 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseM0.00155,8670311,733
Apr 05 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Payment of ExerciseF0.0058,0440100,823158.9 K to 100.8 K (-36.54 %)
Apr 05 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyM0.00155,8670158,8673 K to 158.9 K (+5,195.57 %)
Feb 18 2016MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA0.4920,0009,80020,000
Apr 03 2015MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PChief Financial Off ...Option ExerciseA0.00467,6000467,600
Apr 03 2015MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PChief Financial Off ...Option ExerciseA2.30467,6001,075,480467,600
Dec 14 2006AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVP, CAO & SecretaryGrantA0.0017,400022,5635.2 K to 22.6 K (+337.01 %)
May 26 2006AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, CAOBuyP9.681009685,1635.1 K to 5.2 K (+1.98 %)
May 26 2006AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, CAOBuyP9.671009675,0635 K to 5.1 K (+2.01 %)
May 26 2006AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, CAOBuyP9.693002,9074,9634.7 K to 5 K (+6.43 %)
May 26 2006AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, CAOBuyP9.656005,7904,6634.1 K to 4.7 K (+14.77 %)
Dec 08 2005AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, Fin ...Option ExerciseA2.9245,000131,40045,000
Dec 08 2005AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, Fin ...Option ExerciseA2.9230,00087,60030,000
Nov 12 2004AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, Fin ...Option ExerciseA3.4650,000173,00050,000
Nov 12 2004AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, Fin ...Option ExerciseA3.4650,000173,00050,000
Apr 08 2004AVNRAVANIR PHARMACEUTI ...HANSON GREGORY PVice President, Fin ...Option ExerciseA1.7810,00017,80010,000

Page:   1